“Integrated Computational Design, Green Synthesis, and Characterization of 3,4-Dihydropyrimidine Derivatives Targeting Enoyl-Acyl Carrier Protein Reductase for Tuberculosis Treatment”, Int. J. Res. Pharm. Sci. Technol., vol. 9, no. 3, Aug. 2026, doi: 10.33974/bnb32f45.